Session Title: Toric IOL Outcomes
Session Date/Time: Monday 07/10/2013 | 16:30-18:30
Paper Time: 17:33
Venue: Auditorium (First Floor)
First Author: : O.Moraru ROMANIA
Co Author(s): : I. Iliescu
Purpose:
To present the clinical outcomes in a group of patients operated for cataract with implantion of a new hydrophobic toric intraocular lens (IOL). The rotational stability of the lens was also followed.
Setting:
Oculus Eye Clinic Bucharest Romania
Methods:
This prospective cohort consisted of 18 eyes with medium or advanced cataract and a moderate corneal astigmatism less than 2.0D. After Coaxial Microincision Cataract Surgery (C-MICS), an enVista® toric (Model MX60T) intraocular lens was implanted in the capsular bag. Three toric cylinder powers were evaluated: 1.25D, 2.00D and 2.75 D (IOL plane). The postoperative distance uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), objective and subjective (manifest) refraction, spectacle independence and IOL axis alignment were measured at 1 month. A further 3 months follow-up will also be evaluated.
Results:
The study includes 18 eyes with 1 Month follow-up with preoperative corneal astigmatism from 0.75D to 1.75D. 100% of eyes achieved a postoperative UCVA of 20/40 or better and 87% of 20/30 or better. The postoperative BCVA was 20/25 or better in 93.3% of eyes. The postoperative subjective refractive cylinder was 0.5 D or less in 80% of eyes which shows a high postoperative spectacle independence for distance vision. IOL axis rotation was 5° or less in all eyes with 80% of the eyes with 2 degrees or less of IOL rotation. No complications occurred.
Conclusions:
Our results show that the implantation of the enVista® toric IOL is a safe and effective procedure to correct moderate corneal astigmatism in cataract patients.
Financial Interest:
... travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented
Please wait while information is loading.